Analyst Ratings for Cara Therapeutics (CARA) [Sells]
CARA Rating Summary
CARA Price Target Summary
- Highest: $25.00 (Stifel)
- Lowest: $1.00 (Piper Sandler)
- Average: $12.17
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$12.17 (+1715.9%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 86%
Avg. $ Target:
$12.17 (+1715.9%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 86%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/8/2023 | BofA Securities » Updated 8/9/2023 |
Jason Gerberry | Downgrade | Underperform (Neutral) |
3.50 (4.00) |
10.02 (0.67) |
-93.31% | Details |
